For best experience please turn on javascript and use a modern browser!
Bekijk de site in het Nederlands

The use of nanotechnology for medical purposes (a practice know as nanomedicine) has grown exponentially over the past few decades. Although originally the domain of anticancer therapy, recent advances have shown the considerable potential role of nanomedicine in diagnosing and treating atherosclerosis. Mark Lobatto's research focuses on atherosclerotic disease and nanoparticle-targeting concepts and provides an insight into the use of imaging and nanomedicine in atherosclerosis.

Event details of Using nanotechnology to treat atherosclerotic disease
Date 16 September 2016
Time 12:00 -13:00
Location Agnietenkapel
Room Location

M.E. Lobatto: Exploration and Application of Nanomedicine in Atherosclerotic Disease.

Supervisors

Prof. E.S.G. Stroes

Prof. W.J.M. Mulder

Co-supervisor

Dr J.M. Metselaar (Universiteit Twente)

Agnietenkapel

Room Location

Oudezijds Voorburgwal 229 - 231
1012 EZ Amsterdam

Entrance

This event is open to the public.